Gene therapy today and tomorrow

Molekulyarnaya Biologiya

Volumn 32, Issue 2, 1998, Pages 219-228

  Zelenin, A V ^a   Kaigorodov, V A ^a   Prasolov, V S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE THERAPY; HUMAN; IMMUNOLOGY; NEOPLASM; PREVENTIVE MEDICINE; REVIEW;

GENE THERAPY; HUMANS; NEOPLASMS; PREVENTIVE MEDICINE;

EID: 0032019061     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Friedmann T. II Science. 1989- V. 244. P. 1275-1281,
2. Culver K.W. Gene Therapy. A Handbook for Physicians. N.Y.: Mary Ann Liebert Inc. Publishers, 1994. 117 p.
3. Blase RM.,Culver K.W., Andenan W.F. II Hum. Gene Ther. 1990. V. 1. P. 331-362.
4. Molecular and Cell Biology of Human Gene Therapeutics / Ed Dickson G. London; Glasgow; Weinheim; N.Y.; Tokyo; Melbourn; Madras: Chapman and Hall Publishers, 1995.403p.
5. Gene therapy protocols / Ed Robins P.D. Totowa; New Jersey: Humana Press Inc., 1997. 403 p.
6. Gum T. II Science. 1995. V. 270. P. 575-577.
7. Molecular Biology of Tumor Viruses: RNA Tumor Viruses / Eds Weiss R.A., Teich N., Varmus H.E., Coffin G.M. N.Y.: Cold Spring Harbor Laboratory Press, 2nd edn., 1985. 1233 p.
8. Mann R., Mulligan R.C., Baltimore D. II Cell. 1983. V. 33. P. 153-159.
9. Markowitz D., Goff S., Bank A. II Virology. 1988. V. 167. P. 400-406.
10. Markowitz D., GoffS., Bank A. IIJ. Virol. 1988. V. 162. P. 1120-1124.
11. Kochanek S., Clements P.R, Mitani K. et al. II Proc. Natl. Acad. Sei. USA. 1996. V. 93. P. 5731-5736.
12. Dougherty J.P., Wisni, Yang S. et al. II J. Virol. 1989. V. 63. P. 3209-3212.
13. BettAJ., PrevecL., GrahamFL. III. Virol. 1993. V. 67. P. 5911-5921.
14. Haecker S.E., Stedman H.H., Balice-Jordon R.J. et al. Il Hum. Gene Ther. 1996. V. 7. P. 1907-1914.
15. NaldiniL., B lamer U., Gage F.H. etal. //Proc. Natl Acad. Sei. USA. 1996. V. 93. P. 11382-11388.
16. Klein T.M., Wolf E.D., Wu R., Sanford J.C. II Nature. 1987. V. 327. P.70-73.
17. Zelenin A.V., Titumirov A.V., Kolesnikov V.A. II FEES Lett. 1989. V. 244. P. 65-67.
18. Klein T.M.,Arentzen Z., Lewis P.A., Fitzpatrick-McElligotS. II BioTechnology. 1992. V. 10. P. 286-291.
19. Zelenin AV., Alimov A.A., Titomirov A.V. et al. // FEES Lett. 199 I.V. 280. P. 94-96.
20. KojiecHUKoe B.A., Sejienuna H.A., CeMenoea MJl. u dp. II OHTorenes. 1995. T. 26. P. 467-470.
21. Zelenin A.V., Kolesnikov V.A., Tarasenko O.A. et al. Il FEES Lett. 1997. V. 414. P. 319-322.
22. de Roots W.K., Fallaux F.J., Marinelli A.W.K.S. et al. Il Gene Therapy. 1997. V. 4. P. 55-63.
23. Lai L., Moeckel G.W., Lien Y.H. II Gene Therapy. 1997. V. 4. P. 426-431.
24. Gill D.R., Southern K.W., Mofford K.A. et al. II Gene Therapy. 1997. V. 3. P. 199-209.
25. Thierry A.R.,Rabinovich P. ,PengB. et al. Il Gene Therapy. 1997. V. 4. P. 226-237.
26. Arsacoy S.M., Latoche .I.D., Condor M. et al. Il Gene Therapy. 1997. V. 4. P. 32-35.
27. Nabel E.G., Gordon D., Yang Z.Y. // Hum. Gene Ther. 1992. V. 3. P. 649-656.
28. Whartenby K.A., Abboud C.N., Marrogi A.J. et al. Il Laborat. Investig. 1995. V. 72. P. 131-145.
29. Gene therapy Seminars in Oncology / Eds Lattime E.G., Gerson S.L. 1995. V. 23. 197 p.
30. DranoffG., Jaffee E., Lazenby A. et al. Il Proc. Natl Acad. Sei. USA. 1993. V. 90. P. 3539-3543.
31. Rosenberg S.A. Hi. Clin. Oncol. 1992. V.10. P. ISO199.
32. Rosenberg S.A., Spiess P., Lafreniere R. II Science. 1986. V. 223. P. 1318-1321.
33. Griffith K.D., Read E J., Carrasquillo JA. etal. //]. Natl. Cancer Inst. 1989. V. 81. P. 1709-1717.
34. Hwu P, Yannelli J., Kriegler M. et al. II J. Immunol. 1993. V. 150. P. 4104-4115.
35. Nakamura Y., Wakimoto H., Abe J. et al. II Cancer Res. 1994. V. 54. P. 5757-5760.
36. Hwu P., Yang T.C., Cowherd R. Il Cancer Res. 1995. V. 55. P. 3369-3373.
37. Cole D.J, Weil D.P, Shilyansky J. et al. H Cancer Res. 1995. V. 55. P. 3748-3752.
38. Dilber U.C., Smith C.I.E. II Gene Therapy. 1997. V. 4. P. 273-274.
39. Moolten F.L. II Cancer Res. 1986. V. 46. P. 5276-5281.
40. Freeman S.M., Ramesh R., Marrogi A.J. et al. II Cancer Gene Then 1994. V. 1. P. 326-332.
41. Freeman S.M., Whartenby K.A., Freeman J.L. et al. II Seminars in Oncology. 1996. V. 23. P. 31-45.
42. Estreicher A., Iggo R. II Nature Medicine. 1996. V. 2. P. 1163.
43. Blaese R.M., Culver K.W., Anderson W.F et al. II Hum. Gene Ther. 1993. V. 4. P. 521-527.
44. Culver K.W., Anderson W.F, Blaese RM. // Hum. Gene Ther. 1991.V. 2. P.107-109.
45. Plavec I., Papayannopoulou T., Maury C., Meyer F. II Blood. 1993. V. 81. P. 1384-1392.
46. DiMichele D. // Pediatr. Clin. North Amer. 1996. V. 43. P. 709-736.
47. Hsueh J.I., Qiu X., Zhou J. II Hum. Gene Ther. 1992. V. 3. P. 543-552.
48. Tang D., DeVit M., Johnston S.A. // Nature. 1992. V. 356. P. 152-154.
49. Barry M.A., Barry M.E., Johnston S.A. Il BioTechniques. 1994. V. 16. P. 616-620.
50. fleôaôoe B.r. // MojieKyjiap. ÖHOJioraa. 1997. T. 31. C. 209-215.
51. WolffJA., Mahne R.W., Williams P. et al. Il Science. 1990. V. 247. P. 1465-1468.
52. Sundaram P., Xi W., Brandsma J. L. Il Nucleic Acids Res. 1996. V. 24. P. 1375-1377.
53. Mumpoipanoea E.3., Eaxeanoea B.H., floôpuicoeaE.K). u dp. II MojieKyjinp. OHOJIOFHH. 1997. T. 31. C. 403-406.
54. Boyer J.D., Ugen K.E., Wang B. et al. Il Nature Medicine. 1997. V. 3. P. 526-532.
55. Wilson J.M.,BirinyiL.K., Salomon R.N. et al. Il Science. 1989. V. 244. P. 1344-1346.
56. Flugelman M.Y., Jaklitsch M.T., Newman K.D. et al. Il Curculation. 1992. V. 85. P. 1110-1117.
57. Dichek D.A., Nevill R.F., Zwiebel J.A. // Circulation. 1989. V. 80. P. 1347-1353.
58. Lynch CM., Clowes MM., Osborn W.R. et al. Il Proc. Natl Acad. Sei. USA. 1992. V. 89. P. 1138-1142.
59. Isner J.M.,WalshK., Rosenfield K. et al. Il Human Gene Ther. 1996. V. 7. P. 989-1011.
60. Peavec J., Agarwal M., Ho K.E. et al. // Gene Therapy. 1997. V. 4. P. 128-139.
61. Rossi J.J., Sarver N. Il Adv. Exp. Med. Biol. 1992. V. 312. P. 95-109.
62. Palu G. Il Gene Therapy. 1997. V. 4. P. 179-180.
63. Wilson J.M., Grossman M., Râper S.E. et al. II Hum. Gène Ther. 1992. V. 3. P. 179-222.
64. Sandig V., Strauss M. Il J. Mol. Med. 1996. V. 74. P. 205-212.
65. Rich O.P., Couture LA., Cardoza L.M. et al. Il Hum. Gène Ther. 1993. V. 4. P. 465-476.
66. Gill D.R., Southern K.W., Molford K.A, et al. H Gène Therapy. 1997. V. 4. P. 199-209.
67. Quinonero J., Tcheligerian J-L., Vignais I. et al. Il Gène Therapy. 1997. V. 4. P. 111-119.
68. Porteous D.J., Darin J.R., McLachlan G. et al. // Gène Therapy. 1997. V. 4. P. 210-218.
69. Demoly P., Mathieu M. Il Gene Therapy. 1997. V. 4. P. 507-516.
70. Dunckley M.G., Piper TA., Dickson G. Il Mental Retardation and Developmental Disabilities Res. Rev. 1995. V. 1. P. 71-78.
71. Dickson G. Il Chemistry and Industry. 1996. V. 8. P. 284-297.
72. Fassati A., Dunckley M.G., Dickson G. Il Molecular and cell biology of human gene therapeutics / Ed. Dickson G. London: Chapman and Hall, 1995. P. 1-19.
73. Cox G.A., Cole N.M., Matsumura K. et al II Nature. 1993. V. 364. P. 725-729.
74. Dunckley M.G., Wells DJ., Walsh F.S., Dickson J. et al. // Hum. Mol. Genet. 1993. V. 2. P. 717-723.
75. Yanagihara I., Inui K., Dickson G. et al. Il Gene Therapy. 1996. V. 3. P. 549-553.
76. DecrouyA.,RenaudJ-M.,DavisH.L.étal.//GeneTherapy. 1997. V. 4. P. 401-408.
77. Barr E., Leiden J.M. II Science. 1991. V. 254. P. 15071509.
78. SendtnerM. //Nature Medicine. 1997. V. 3. P. 380-381.
79. Mao S., Cheng L., WotffJA., Yang N S. II BioTechnology. 1993. V. 11. P. 497-502.
80. Jiao S., Jurevich V., WolffJA. II Science. 1993. V. 362. P. 450-453.
81. Mouradian MM., Chase T.N. II Gene Therapy. 1997. V. 4. P. 504-506.
82. Andrée C., Swain W.F., Page C.P.et al. II Proc. Natl Acad. Sei. 1994. V. 91. P. 12188-12192.
83. Choate K A., Morgan J.R, fChavare P. II Nature Medicine. 1996. V. 2. P. 1263-1267.
84. De Luca M., Peltegrini G. II Gene Therapy. 1997. V. 4. P. 381-383.
85. Evans Ch.H., Mankin H J. Ferguson A.B. // Hum. Gene Ther. 1996. V. 7. P. 1261-1280.
86. Fletcher J.C., Richter G. II Hum. Gene Ther. 1996. V. 7. P. 1605-1614.
87. Jacomino M., Lau Ch., James S.Z. et al. II Hum. Gene Ther. 1996. V. 7. P. 1757-1762.